|
MED26 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.078300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.726400E-01 |
| Normal-vs-Stage2 |
6.843600E-01 |
| Normal-vs-Stage3 |
7.425900E-02 |
| Normal-vs-Stage4 |
1.255600E-01 |
| Stage1-vs-Stage2 |
7.038800E-01 |
| Stage1-vs-Stage3 |
2.055800E-01 |
| Stage1-vs-Stage4 |
4.226200E-01 |
| Stage2-vs-Stage3 |
2.065000E-01 |
| Stage2-vs-Stage4 |
2.666600E-01 |
| Stage3-vs-Stage4 |
9.728600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.849900E-02 |
| Normal-vs-AfricanAmerican |
2.409000E-01 |
| Normal-vs-Asian |
7.519800E-02 |
| Caucasian-vs-AfricanAmerican |
8.865400E-01 |
| Caucasian-vs-Asian |
4.354400E-01 |
| AfricanAmerican-vs-Asian |
3.799800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.090420E-01 |
| Normal-vs-Female |
2.050300E-02 |
| Male-vs-Female |
1.785820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.635800E-01 |
| Normal-vs-Extreme_Weight |
2.769600E-01 |
| Normal-vs-Obese |
1.017970E-02 |
| Normal-vs-Extreme_Obese |
9.342400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.795200E-01 |
| Normal_Weight-vs-Obese |
2.098200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.246800E-01 |
| Extreme_Weight-vs-Obese |
9.437800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.490800E-01 |
| Obese-vs-Extreme_Obese |
1.313010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.358700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.226110E-02 |
| Normal-vs-Age(61-80Yrs) |
6.022800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.825400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.291620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.944200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.560600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.620040E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.373650E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.632800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.129900E-02 |
| Normal-VS-Type2 PRCC |
2.019800E-01 |
| Normal-VS-KIRP CIMP |
4.608900E-04 |
| Normal-VS-Unclassified PRCC |
7.782000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.04360000003001E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.691800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.896800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.27480000000369E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.736200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.442200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.580400E-01 |
| Normal-vs-N1 |
1.778360E-03 |
| Normal-vs-N2 |
2.482000E-01 |
| N0-vs-N1 |
1.197610E-03 |
| N0-vs-N2 |
3.197200E-01 |
| N1-vs-N2 |
5.529400E-01 |
|
|
